tirzepatide kidney stones Can GLP‑1 medications increase stone risk? A UAB urologist offers insight Can Tirzepatide Cause Kidney Stones?
Description
Its probably reversible
Learn what this case means for GLP-1 safety and compliance.
It has been approved for use in the treatment of type 2 diabetes.
Congratulations to the authorsAmalie Dyrelund Broks, Mads Brner Kristensen,Bolette Hartmann,Knud Josefsen,Jens Juul Holst, and Tue Kragstrupfor theirwork - and forhelping chartexciting new research avenues and novel treatment approaches for patients. You canfindthe paper, Detection of GLP-1 and DPP-4 in synovial fluid: implications for therapeutical strategies in arthriti, here: #GLP1 #Rheumatology #Arthritis #TranslationalResearch #ClinicalResearch #Inflammation
Subjects and methods: This cross-sectional study included 41 individuals (92.7% women
The GLP-1 market is poised for unprecedented growth over the next 5 years, presenting a unique opportunity for digital health behavioral change
